Shingles Vaccine Shortages Result From High Demand

Letto da: Kristi Burns
Durata: 4 min
Dopo 30 giorni EUR 9,99/mese

Sintesi dell'editore

Shingrix, the vaccine approved last year to prevent shingles, has proved so popular that its maker, GlaxoSmithKline, has not been able to produce it quickly enough to keep up with the demand.

"Shingles Vaccine Shortages Result From High Demand" is from the September 25, 2018 U.S. section of The New York Times. It was written by Denise Grady and narrated by Kristi Burns.

©2017 The New York Times News Service Division of The New York Times Company (P)2017 Audible, Inc.
Cosa ne pensano gli iscritti
Valutazione media degli utenti

Non ci sono recensioni disponibili